Invasive fungal disease (IFD) is a common cause of morbidity and mortality in patients with
hematologic malignancies, especially among those undergoing allogeneic hematopoietic …

Patients with haematological malignancies, haemopoietic stem cell transplant recipients and
patients requiring admission to intensive care settings are at high risk for invasive …

Background Mortality rates among adults with candidemia vary widely in different
geographical settings. Studies directly comparing epidemiology and clinical practices …

Invasive fungal diseases (IFD) are serious infections associated with high mortality,
particularly in immunocompromised patients. The prescribing of antifungal agents to prevent …

Introduction Intra-abdominal infections represent the second most frequently acquired
infection in the intensive care unit (ICU), with mortality rates ranging from 20% to 50 …

Background The objective of this study was to compare the clinical outcomes of patients
receiving a short course (SC) vs a prolonged course (PC) of antifungal therapy for …

Background Recently, several scores to quantify compliance with the guidelines in
candidaemia management (EQUAL, GEMICOMED, Valerio) have been developed …

Introduction Enterococcus spp is responsible for 8%–15% of total bacteraemias with an
associated global mortality around 23%–30%. Regarding the clinical management of …

Methods The INTENSE study is a multicentre, open-label, randomised, pragmatic, phase-IV
clinical trial to demonstrate the non-inferiority of a 7-day vs 14-day course for the treatment of …

Evidence for the utility of pharmacist-driven antimicrobial stewardship programs remains
limited. This study aimed to evaluate the usefulness of our institutional pharmacist-driven …